Compared with the MTX, WTD significantly decreased the 28-joint disease activity score (DAS28) and the levels of TNF-α and IL-6 in RA patients with cold-damp syndrome, furthermore, it can improve clinical symptoms and significantly reduce the serum levels of pro-inflammatory cytokines in RA patients (34). The gene discussed is TNF; the disease is rheumatoid arthritis.